{"DataElement":{"publicId":"6400808","version":"1","preferredName":"Concomitant Meds Dose Form","preferredDefinition":"The pharmaceutical dosage form in which the CMTRT is physically presented.","longName":"CMDOSFRM","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6400444","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Dose Form","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._The dosage form of the concomitant medication.","longName":"4550855v1.0:6400442v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4550855","version":"1","preferredName":"Concomitant Medication Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","longName":"C49568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Domain","conceptCode":"C49568","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06047D53-A3ED-FF3E-E050-BB89AD430B5B","latestVersionIndicator":"Yes","beginDate":"2014-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-22","modifiedBy":"ONEDATA","dateModified":"2014-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6400442","version":"1","preferredName":"Concomitant Medication Dose Form","preferredDefinition":"The dosage form of the concomitant medication.","longName":"C83110","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Dose Form","conceptCode":"C83110","definition":"The dosage form of the concomitant medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"736A32EA-3898-5774-E053-F662850A6204","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"736A32EA-38A9-5774-E053-F662850A6204","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"HARTLEYG","dateModified":"2020-06-17","changeDescription":"created for CDASH 8/14/18LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6400807","version":"1","preferredName":"CDISC CDASH Concomitant Medication Dose Form Terminology Type","preferredDefinition":"A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Pharmaceutical Dosage Form codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Form terminology._Something distinguishable as an identifiable class based on common qualities.","longName":"CMDOSFRM","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"AEROSOL","valueDescription":"Aerosol Dosage Form","ValueMeaning":{"publicId":"2578774","version":"1","preferredName":"Aerosol Dosage Form","longName":"2578774","preferredDefinition":"A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aerosol Dosage Form","conceptCode":"C42887","definition":"Contents packaged under pressure that are released upon activation of an appropriate valve system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-00C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-01","modifiedBy":"ONEDATA","dateModified":"2006-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5F82-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"CAPSULE","valueDescription":"Capsule Dosage Form","ValueMeaning":{"publicId":"5796808","version":"1","preferredName":"Capsule Dosage Form","longName":"5796808","preferredDefinition":"A solid contained within either a hard or soft soluble shell, usually prepared from gelatin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capsule Dosage Form","conceptCode":"C25158","definition":"A solid contained within either a hard or soft soluble shell, usually prepared from gelatin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E41835B-2FB4-6E12-E053-F662850ABE95","latestVersionIndicator":"Yes","beginDate":"2017-04-28","endDate":null,"createdBy":"DAVISJ","dateCreated":"2017-04-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5F8C-7CFD-E053-F662850AC9C1","beginDate":"2018-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"CREAM","valueDescription":"Cream Dosage Form","ValueMeaning":{"publicId":"2660008","version":"1","preferredName":"Cream Dosage Form","longName":"2660008","preferredDefinition":"A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cream Dosage Form","conceptCode":"C28944","definition":"A semi-solid composed of an emulsion of lipids, hydrocarbons, waxes, or polyols in water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-DF20-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"ONEDATA","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5F96-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"GAS","valueDescription":"Gas Dosage Form","ValueMeaning":{"publicId":"2579032","version":"1","preferredName":"Gas Dosage Form","longName":"2579032","preferredDefinition":"Any elastic aeriform fluid in which the molecules are separated from one another and have free paths.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gas Dosage Form","conceptCode":"C42933","definition":"An elastic aeriform fluid in which the molecules are separated from one another and have freedom of movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-01C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-03","modifiedBy":"ONEDATA","dateModified":"2006-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FA0-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"GEL","valueDescription":"Gel Dosage Form","ValueMeaning":{"publicId":"2579033","version":"1","preferredName":"Gel Dosage Form","longName":"2579033","preferredDefinition":"A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gel Dosage Form","conceptCode":"C42934","definition":"A semi-solid composed of a solid, three dimensional, cross linked matrix of polymers within a liquid, yielding a jelly-like material unable to flow at steady state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-01C6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-03","modifiedBy":"REEVESD","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FAA-7CFD-E053-F662850AC9C1","beginDate":"2018-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"OINTMENT","valueDescription":"Ointment Dosage Form","ValueMeaning":{"publicId":"2579098","version":"1","preferredName":"Ointment Dosage Form","longName":"2579098","preferredDefinition":"A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ointment Dosage Form","conceptCode":"C42966","definition":"A semi-solid, viscous in texture, that may be composed of a variety of bases including hydrocarbons, emulsifiers or vegetable oils, and mixed with active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0207-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"REEVESD","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FB4-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"PATCH","valueDescription":"Patch Dosage Form","ValueMeaning":{"publicId":"2579102","version":"1","preferredName":"Patch Dosage Form","longName":"2579102","preferredDefinition":"A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System.  ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patch Dosage Form","conceptCode":"C42968","definition":"A solid composed of an impermeable occlusive backing and a formulation matrix in which the active and/or inert ingredient(s) are dissolved or dispersed; possibly includes an adhesive layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-020B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"REEVESD","dateModified":"2006-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FBE-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"POWDER","valueDescription":"Powder Dosage Form","ValueMeaning":{"publicId":"2579111","version":"1","preferredName":"Powder Dosage Form","longName":"2579111","preferredDefinition":"An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Powder Dosage Form","conceptCode":"C42972","definition":"A solid composed of a mixture of dry, finely divided active and/or inert ingredient(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0214-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FC8-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"SPRAY","valueDescription":"Spray Dosage Form","ValueMeaning":{"publicId":"2579132","version":"1","preferredName":"Spray Dosage Form","longName":"2579132","preferredDefinition":"A liquid minutely divided as by a jet of air or steam.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spray Dosage Form","conceptCode":"C42989","definition":"A solution or suspension composed of active and/or inert ingredient(s) in oil or water, typically dispensed from an atomizer or nebulizer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0229-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FD2-7CFD-E053-F662850AC9C1","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"SUPPOSITORY","valueDescription":"Suppository Dosage Form","ValueMeaning":{"publicId":"2579138","version":"1","preferredName":"Suppository Dosage Form","longName":"2579138","preferredDefinition":"A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suppository Dosage Form","conceptCode":"C42993","definition":"A solid or semi-solid composed of active and/or inert ingredient(s) in a wax, fat or a glycerin gelatin jelly and that is conical or oval in shape. It is intended to be inserted into a body orifice.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-022F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FDC-7CFD-E053-F662850AC9C1","beginDate":"2018-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"SUSPENSION","valueDescription":"Suspension Dosage Form","ValueMeaning":{"publicId":"2579139","version":"1","preferredName":"Suspension Dosage Form","longName":"2579139","preferredDefinition":"A liquid preparation which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suspension Dosage Form","conceptCode":"C42994","definition":"Insoluble solid particles composed of active and/or inert ingredient(s) that are dispersed in a liquid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0230-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FE6-7CFD-E053-F662850AC9C1","beginDate":"2018-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"},{"value":"TABLET","valueDescription":"Tablet Dosage Form","ValueMeaning":{"publicId":"2579144","version":"1","preferredName":"Tablet Dosage Form","longName":"2579144","preferredDefinition":"A solid dosage form containing medicinal substances with or without suitable diluents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tablet Dosage Form","conceptCode":"C42998","definition":"A solid composed of a mixture of that active and/or inert ingredient(s) are pressed or compacted together, usually in the form of a relatively flat and round, square or oval shape.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0235-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"ONEDATA","dateModified":"2006-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"737B73B1-5FF0-7CFD-E053-F662850AC9C1","beginDate":"2018-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6400806","version":"1","preferredName":"CDISC CDASH Concomitant Medication Dose Form Terminology Type","preferredDefinition":"A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Pharmaceutical Dosage Form codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Form terminology.:Something distinguishable as an identifiable class based on common qualities.","longName":"C78418:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC CDASH Concomitant Medication Dose Form Terminology","conceptCode":"C78418","definition":"A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Pharmaceutical Dosage Form codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Form terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"737B73B1-5F5B-7CFD-E053-F662850AC9C1","latestVersionIndicator":"Yes","beginDate":"2018-08-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ONEDATA","dateModified":"2018-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"737B73B1-5F6C-7CFD-E053-F662850AC9C1","latestVersionIndicator":"Yes","beginDate":"2018-08-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"COOPERM","dateModified":"2020-10-20","changeDescription":"8-15-18 Created as part of the CDISC mapping task; tt. 10.20.20 Released for reuse by CTEP CDE Harmonization. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6338162","version":"1","longName":"CDISC (NCI Implementation)","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6338163","version":"1","longName":"CDASH","context":"NCI Standards"},{"publicId":"7329805","version":"1","longName":"Optional Core","context":"NCI Standards"},{"publicId":"7329788","version":"1","longName":"Concomitant Medication (CM) Domain","context":"NCI Standards"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685479","version":"1","longName":"Testing Set – Semantically Different","context":"NCIP"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7473999","version":"1","longName":"CTEP CDISC Concomitant Medication","context":"CTEP"}]}],"AlternateNames":[{"name":"CM.CMDOSFRM","type":"Map:CDASHv1.1","context":"NCIP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"CM_CMDOSFRM","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"What was the dose form of the","type":"Preferred Question Text","description":"What was the dose form of the (concomitant) [medication/treatment/therapy]?","url":null,"context":"NCI Standards"},{"name":"CDASH Prompt","type":"Alternate Question Text","description":"Dose Form","url":null,"context":"NCI Standards"},{"name":"CDISC CDASH Concomitant Medication Dose Form Terminology","type":"VALID_VALUE_SOURCE","description":"A terminology subset of the CDISC Study Data Tabulation Model (SDTM) Pharmaceutical Dosage Form codelist created for Clinical Data Acquisition Standards Harmonization (CDASH) Concomitant Medication Dose Form terminology.","url":"https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C78418","context":"NCI Standards"},{"name":"Case Report Form Completion Instructions","type":"CDISC CRF Instruction","description":"Record the pharmaceutical dosage form (e.g., TABLET CAPSULE, SYRUP) of delivery for the concomitant [medication/treatment/therapy] taken.","url":null,"context":"NCI Standards"},{"name":"CMDOSFRM","type":"CDASH to SDTM Mapping","description":"Maps directly to the SDTMIG variable.","url":null,"context":"NCI Standards"},{"name":"CDASH Implementation Notes","type":"CDASH Implementation Note","description":"Some drugs have multiple forms and this field may be needed to code the drug to an ATC level. However, in general, this level of detail should not be necessary except for medications/treatments of interest.","url":null,"context":"NCI Standards"},{"name":"What was the dose form?","type":"Alternate Question Text","description":"What was the dose form?","url":null,"context":"CTEP"},{"name":"Dose form","type":"Alternate Question Text","description":"Dose form","url":null,"context":"CTEP"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"737BAA23-78BC-6F8D-E053-F662850A48E9","latestVersionIndicator":"Yes","beginDate":"2018-08-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-15","modifiedBy":"ZHWENDY","dateModified":"2023-12-08","changeDescription":"8-15-18 Created as part of the CDISC mapping task; tt. 10.20.20 Released for reuse by CTEP CDE Harmonization. mc","administrativeNotes":"12/8/2023: updated per caDRS0003171.wz","unresolvedIssues":null,"deletedIndicator":"No"}}